These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. Ober M; Scharrer A; Dausch D Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660 [TBL] [Abstract][Full Text] [Related]
4. Management of chronic glaucoma with pilocarpine Ocuserts. Hillman JS; Walker A; Davies EM Trans Ophthalmol Soc U K (1962); 1977 Apr; 97(1):206-9. PubMed ID: 339415 [TBL] [Abstract][Full Text] [Related]
5. Effect of adding betaxolol to dipivefrin therapy. Weinreb RN; Ritch R; Kushner FH Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535 [TBL] [Abstract][Full Text] [Related]
6. Pilocarpine and dipivefrin. Cantor LB CLAO J; 1991 Apr; 17(2):134. PubMed ID: 2049823 [No Abstract] [Full Text] [Related]
8. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure]. Ober M; Scharrer A Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479 [TBL] [Abstract][Full Text] [Related]
9. [The pressure reducing effects of pilocarpin in combination with Dipivalyl-epinephrine in glaucoma simplex (author's transl)]. Krieglstein GK; Leydhecker W Klin Monbl Augenheilkd; 1979 Jul; 175(1):86-90. PubMed ID: 491472 [TBL] [Abstract][Full Text] [Related]
10. The Ocusert pilocarpine system: advantages and disadvantages. Pollack IP; Quigley HA; Harbin TS South Med J; 1976 Oct; 69(10):1296-8. PubMed ID: 982104 [TBL] [Abstract][Full Text] [Related]
11. The long-acting Ocusert-pilocarpine system in the management of glaucoma. Lee P; Shen Y; Eberle M Invest Ophthalmol; 1975 Jan; 14(1):43-6. PubMed ID: 1110136 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the pupillary, refractive, and hypotensive effects of Ocusert-40 and pilocarpine eyedrops in the treatment of chronic simple glaucoma. Smith SE; Smith SA; Friedmann AI; Chaston JM Br J Ophthalmol; 1979 Apr; 63(4):228-32. PubMed ID: 435437 [TBL] [Abstract][Full Text] [Related]
13. Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. Widengård I; Mäepea O; Alm A Br J Ophthalmol; 1998 Apr; 82(4):404-6. PubMed ID: 9640189 [TBL] [Abstract][Full Text] [Related]
14. [A myopia study of glaucoma patients following pilocarpine instillation]. Pop I; Ban C; Hanciu D; Petroi C Oftalmologia; 2000; 52(3):44-8. PubMed ID: 11021139 [TBL] [Abstract][Full Text] [Related]
15. Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications. Sharir M; Zimmerman TJ J Assoc Acad Minor Phys; 1994; 5(2):62-7. PubMed ID: 8032178 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of Ocusert Pilo 40, intensive pilocarpine and low-dose pilocarpine in the initial treatment of primary acute angle-closure glaucoma. Edwards RS Curr Med Res Opin; 1997; 13(9):501-9. PubMed ID: 9169252 [TBL] [Abstract][Full Text] [Related]
17. Side effects of topical treatment in pigmentary glaucoma. Lehto I Acta Ophthalmol (Copenh); 1992 Apr; 70(2):225-7. PubMed ID: 1609572 [TBL] [Abstract][Full Text] [Related]
18. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine]. Alimgil ML; Erda S; Benian O Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405 [No Abstract] [Full Text] [Related]